Boehringer Ingelheim

Boehringer wins EU approval for Humira biosimilar
BioPharma Dive
Wed, 11/15/17 - 08:53 pm
Boehringer Ingelheim
Europe
Humira
biosimilars
Cyltezo
AbbVie
GlaxoSmithKline's Anoro tops Boehringer's Stiolto in head-to-head COPD tilt
Fierce Pharma
Sat, 11/4/17 - 08:44 am
GSK
Anoro Ellipta
Boehringer Ingelheim
Stiolto Respimat
COPD
Dicerna and Boehringer partner on RNAi treatment for NASH
Endpoints
Thu, 11/2/17 - 11:14 am
Dicerna
Boehringer Ingelheim
NASH
RNAi
Boehringer Ingelheim, Anthem partner for largest real-world COPD trial
Drug Delivery Business News
Thu, 10/12/17 - 10:19 pm
Boehringer Ingelheim
Anthem
COPD
Boehringer's new risk-prediction model will tap patients who could be good Jardiance candidates
Fierce Pharma
Wed, 09/27/17 - 11:19 am
Boehringer Ingelheim
Eli Lilly
Jardiance
diabetes
EASD: Boehringer Ingelheim, Lilly's Jardiance holds CV benefit regardless of blood sugar starting point
Fierce Pharma
Thu, 09/14/17 - 11:27 am
EASD
Boehringer Ingelheim
Eli Lilly
Jardiance
diabetes
Boehringer Ingelheim/Pharmaxis start Phase IIa trial in NASH
GoInPharma
Wed, 08/30/17 - 11:45 pm
Boehringer Ingelheim
Pharmaxis
NASH
clinical trials
BI 1467335
CVS formulary knocks Lilly, BI's Jardiance in favor of J&J's Invokana
Fierce Pharma
Wed, 08/2/17 - 11:57 am
formulary
Eli Lilly
Boehringer Ingelheim
JNJ
Invokana
diabetes
CVS Caremark
J&J's Invokana continues downward market-share spiral as Lilly, BI's Jardiance advances
Fierce Pharma
Wed, 07/19/17 - 07:47 pm
JNJ
Invokana
Eli Lilly
Boehringer Ingelheim
Jardiance
diabetes
This Secretive Clan Wants to Beat the World’s Biggest Drugmakers
Bloomberg
Mon, 07/17/17 - 09:50 pm
Boehringer Ingelheim
Key Humira patent gets struck down for the second time in as many months
Fierce Pharma
Sun, 07/9/17 - 11:38 am
Humira
patents
AbbVie
Boehringer Ingelheim
Coherus Biosciences
BI, Lilly hit the streets to talk up Jardiance's cardiovascular benefits
Fierce Pharma
Wed, 06/28/17 - 10:13 am
Boehringer Ingelheim
Eli Lilly
Jardiance
drug ads
DTC advertising
AstraZeneca, Boehringer cry 'no class effect' after Johnson & Johnson's Invokana doubles amputations in study
Fierce Pharma
Wed, 06/14/17 - 09:00 pm
AstraZeneca
Boehringer Ingelheim
JNJ
Invokana
diabetes
Jardiance
amputation
J&J's Invokana lowers CV risk, but by enough to compete?
BioPharma Dive
Wed, 06/14/17 - 11:37 am
JNJ
Invokana
diabetes
Jardiance
Eli Lilly
Boehringer Ingelheim
ADA: Merck, Pfizer notch success, but late with SGLT-2 data
BioPharma Dive
Tue, 06/13/17 - 12:15 pm
diabetes
Merck
Pfizer
SGLT2 inhibitor
Januvia
Invokana
Farxiga
Jardiance
Eli Lilly
Boehringer Ingelheim
AstraZeneca
JNJ
J&J Drug Prevents Heart Attacks At Cost Of Amputated Toes
Forbes
Mon, 06/12/17 - 10:15 pm
JNJ
heart attacks
Invokana
diabetes
amputation. Eli Lilly
Boehringer Ingelheim
Jardiance
ADA preview: 5 things to watch in diabetes
BioPharma Dive
Sun, 06/11/17 - 09:30 am
ADA
diabetes
Jardiance
Eli Lilly
Boehringer Ingelheim
Lantus
Tresiba
JNJ
Novo Nordisk
PCSK9 inhibitors
Amgen Regeneron
Sanofi
Apple
Google
insulin
Boehringer Ingelheim opens large manufacturing facility in China
BioPharma Dive
Thu, 05/18/17 - 07:54 pm
Boehringer Ingelheim
China
drug manufacturing
Pradaxa’s 'Red Fish' go to the aquarium in new Boehringer campaign
Fierce Pharma
Mon, 05/8/17 - 11:35 am
Boehringer Ingelheim
Pradaxa
drug ads
television ads
bloodthinners
Boehringer eyes marked sales gain, boosted by animal health
Yahoo/Reuters
Thu, 04/6/17 - 09:26 am
Boehringer Ingelheim
animal health
earnings

Pages